​

CME Group (CME) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

CME Stock Forecast

CME Group (CME) stock forecast, based on 34 Wall Street analysts, predicts a 12-month average price target of $296.20, with a high of $314.00 and a low of $280.00. This represents a 9.26% increase from the last price of $271.09.

$150 $190 $230 $270 $310 $350 High: $314 Avg: $296.2 Low: $280 Last Closed Price: $271.09

CME Stock Rating

CME Group stock's rating consensus is Hold, based on 34 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 13 Buy (38.24%), 16 Hold (47.06%), 5 Sell (14.71%), and 0 Strong Sell (0.00%).

Hold
Total 34 0 5 16 13 Strong Sell Sell Hold Buy Strong Buy

CME Price Target Upside V Benchmarks

TypeNameUpside
StockCME Group9.26%
SectorFinancial Services Stocks 8.06%
IndustryFinancial Data & Stock Exchanges Stocks15.17%
IdeaBlockchain Stocks List5.83%
IdeaCrypto Stocks List13.90%

Price Target Trends

1M3M12M
# Anlaysts679
Avg Price Target$298.83$296.86$295.89
Last Closing Price$271.09$271.09$271.09
Upside/Downside10.23%9.51%9.15%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Oct, 253471318
Sep, 253381318
Aug, 253381318
Jul, 25347-418
Jun, 25347-418
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Oct 23, 2025Michael CyprysMorgan Stanley$314.00$269.5016.51%15.83%
Oct 23, 2025Alex KrammUBS$280.00$267.814.55%3.29%
Oct 23, 2025Deutsche Bank$300.00$269.5911.28%10.66%
Oct 13, 2025Patrick O'ShaughnessyRaymond James$307.00$271.4513.10%13.25%
Oct 08, 2025Barclays$280.00$263.606.22%3.29%
Oct 01, 2025Morgan Stanley$312.00$264.4717.97%15.09%
Sep 08, 2025Alex KrammUBS$285.00$261.788.87%5.13%
Jul 24, 2025Benjamin BudishBarclays$298.00$277.187.51%9.93%
Mar 10, 2025Patrick O'ShaughnessyRaymond James$287.00$254.5712.74%5.87%
Oct 24, 2024Owen LauOppenheimer$258.00$227.4313.44%-4.83%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Oct 23, 2025Morgan StanleyOverweightOverweighthold
Oct 23, 2025UBSNeutralNeutralhold
Oct 23, 2025Deutsche BankHoldBuyupgrade
Oct 13, 2025Raymond JamesOutperformOutperformhold
Oct 01, 2025Morgan StanleyOverweightOverweighthold
Sep 25, 2025CitigroupBuyBuyupgrade
Sep 08, 2025UBSNeutralNeutralhold
Mar 10, 2025Raymond JamesSellOutperformupgrade
Oct 24, 2024CitigroupBuyBuyhold
Oct 17, 2024Morgan StanleyEqual-WeightEqual-Weighthold

Financial Forecast

EPS Forecast

$5 $6 $7 $8 $9 $10 $11 $12 $13 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$5.88$7.30$7.41$8.87$9.69----
Avg Forecast$6.73$6.68$7.94$9.25$10.19$10.39$10.93$11.66$12.60
High Forecast$6.99$6.93$8.15$9.31$10.23$10.65$11.67$12.50$12.98
Low Forecast$6.47$6.42$7.59$9.21$10.15$10.09$9.82$10.82$12.04
Surprise %-12.63%9.28%-6.68%-4.11%-4.91%----

Revenue Forecast

$5B $5B $6B $7B $7B $8B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$4.88B$4.69B$5.02B$5.58B$6.13B----
Avg Forecast$4.88B$4.71B$5.02B$5.57B$6.11B$6.28B$6.57B$6.94B$7.39B
High Forecast$5.03B$4.84B$5.13B$5.58B$6.12B$6.41B$6.59B$7.04B$7.56B
Low Forecast$4.74B$4.57B$4.85B$5.55B$6.10B$6.15B$6.56B$6.84B$7.14B
Surprise %0.00%-0.35%-0.02%0.16%0.26%----

Net Income Forecast

$2B $2B $3B $4B $4B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.11B$2.64B$2.69B$3.23B$3.48B----
Avg Forecast$2.07B$2.58B$3.00B$3.19B$3.66B$3.73B$3.69B$4.19B$4.53B
High Forecast$2.48B$3.09B$3.60B$3.82B$3.68B$3.83B$4.19B$4.49B$4.67B
Low Forecast$1.66B$2.06B$2.40B$2.55B$3.65B$3.63B$3.53B$3.89B$4.33B
Surprise %1.69%2.35%-10.20%1.27%-4.96%----

CME Forecast FAQ

Is CME Group stock a buy?

CME Group stock has a consensus rating of Hold, based on 34 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 13 Buy, 16 Hold, 5 Sell, and 0 Strong Sell, reflecting a consensus that CME Group is a neutral investment for most analysts.

What is CME Group's price target?

CME Group's price target, set by 34 Wall Street analysts, averages $296.2 over the next 12 months. The price target range spans from $280 at the low end to $314 at the high end, suggesting a potential 9.26% change from the previous closing price of $271.09.

How does CME Group stock forecast compare to its benchmarks?

CME Group's stock forecast shows a 9.26% upside, outperforming the average forecast for the financial services stocks sector (8.06%) and underperforming the financial data & stock exchanges stocks industry (15.17%), leading the blockchain stocks list (5.83%) investment idea while trailing the Crypto Stocks List (13.90%) investment idea.

What is the breakdown of analyst ratings for CME Group over the past three months?

  • October 2025: 16.67% Strong Buy, 22.22% Buy, 38.89% Hold, 5.56% Sell, 16.67% Strong Sell.
  • September 2025: 16.67% Strong Buy, 16.67% Buy, 44.44% Hold, 5.56% Sell, 16.67% Strong Sell.
  • August 2025: 16.67% Strong Buy, 16.67% Buy, 44.44% Hold, 5.56% Sell, 16.67% Strong Sell.

What is CME Group’s EPS forecast?

CME Group's average annual EPS forecast for its fiscal year ending in December 2025 is $10.39, marking a 7.22% increase from the reported $9.69 in 2024. Estimates for the following years are $10.93 in 2026, $11.66 in 2027, and $12.6 in 2028.

What is CME Group’s revenue forecast?

CME Group's average annual revenue forecast for its fiscal year ending in December 2025 is $6.28B, reflecting a 2.39% increase from the reported $6.13B in 2024. The forecast for 2026 is $6.57B, followed by $6.94B for 2027, and $7.39B for 2028.

What is CME Group’s net income forecast?

CME Group's net income forecast for the fiscal year ending in December 2025 stands at $3.73B, representing an 7.05% increase from the reported $3.48B in 2024. Projections indicate $3.69B in 2026, $4.19B in 2027, and $4.53B in 2028.